Immuneering Corp - Class A common stock, par value $0.001 per share (IMRX)

CUSIP: 45254E107

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / Class A common stock, par value $0.001 per share
Shares outstanding
66,027,379
Total 13F shares
11,722,865
Share change
-330,043
Total reported value
$56,864,840
Price per share
$4.85
Number of holders
32
Value change
-$4,241,513
Number of buys
14
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 45254E107?
CUSIP 45254E107 identifies IMRX - Immuneering Corp - Class A common stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Immuneering Corp - Class A common stock, par value $0.001 per share (IMRX) as of Q4 2022

As of 31 Dec 2022, Immuneering Corp - Class A common stock, par value $0.001 per share (IMRX) was held by 32 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,722,865 shares. The largest 10 holders included PRICE T ROWE ASSOCIATES INC /MD/, Cormorant Asset Management, LP, CITADEL ADVISORS LLC, BlackRock Inc., VANGUARD GROUP INC, T. Rowe Price Investment Management, Inc., GEODE CAPITAL MANAGEMENT, LLC, FMR LLC, TD Asset Management Inc, and MANUFACTURERS LIFE INSURANCE COMPANY, THE. This page lists 32 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.